163 related articles for article (PubMed ID: 11460306)
41. Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model.
Nakamura T; Fukiage M; Suzuki Y; Yano I; Miyazaki J; Nishiyama H; Akaza H; Harashima H
J Control Release; 2014 Dec; 196():161-7. PubMed ID: 25315488
[TBL] [Abstract][Full Text] [Related]
42. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
Azuma I; Yamamura Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
[No Abstract] [Full Text] [Related]
43. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
44. Isolation and identification of arabinose mycolates of Cell Wall Skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105).
Uenishi Y; Kusunose N; Yano I; Sunagawa M
J Microbiol Methods; 2010 Mar; 80(3):302-5. PubMed ID: 20079769
[TBL] [Abstract][Full Text] [Related]
45. Does the cell wall skeleton from Bacille Calmette-Guérin directly induce interferon-gamma, independent of interleukin-12?
Hayashi A; Noda A
Jpn J Clin Oncol; 1996 Jun; 26(3):124-7. PubMed ID: 8656550
[TBL] [Abstract][Full Text] [Related]
46. Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.
Kodama K; Higashiyama M; Takami K; Oda K; Okami J; Maeda J; Akazawa T; Matsumoto M; Seya T; Wada M; Toyoshima K
Surg Today; 2009; 39(3):194-200. PubMed ID: 19280277
[TBL] [Abstract][Full Text] [Related]
47. Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency.
Yanagawa E; Yasumoto K; Ohta M; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Apr; 70(2):141-6. PubMed ID: 381087
[TBL] [Abstract][Full Text] [Related]
48. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
49. Immunological adjuvants in cancer immunotherapy.
Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
[No Abstract] [Full Text] [Related]
50. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
51. Phase I study of iv mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose dimycolate.
Vosika GJ; Gray GR
Cancer Treat Rep; 1983 Sep; 67(9):785-90. PubMed ID: 6883355
[TBL] [Abstract][Full Text] [Related]
52. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
53. BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection.
Kim KH; Lee YT; Park Y; Ko EJ; Jung YJ; Kim YJ; Jo EK; Kang SM
Biomedicines; 2021 May; 9(5):. PubMed ID: 34063125
[TBL] [Abstract][Full Text] [Related]
54. Distribution of BCG-CWS-Loaded Nanoparticles in the Spleen After Intravenous Injection Affects Cytotoxic T Lymphocyte Activity.
Masuda H; Nakamura T; Harashima H
J Pharm Sci; 2020 Jun; 109(6):1943-1950. PubMed ID: 32070704
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells.
von Meyenn F; Schaefer M; Weighardt H; Bauer S; Kirschning CJ; Wagner H; Sparwasser T
Immunobiology; 2006; 211(6-8):557-65. PubMed ID: 16920494
[TBL] [Abstract][Full Text] [Related]
56. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
[TBL] [Abstract][Full Text] [Related]
57. Immunoadjuvants for cancer immunotherapy: A review of recent developments.
Banstola A; Jeong JH; Yook S
Acta Biomater; 2020 Sep; 114():16-30. PubMed ID: 32777293
[TBL] [Abstract][Full Text] [Related]
58. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
59. Prophylactic effect of BCG cell-wall skeleton on the tumor induction by 7,12-dimethylbenz[a]anthracene in mice: strain difference.
Ikegami R; Takatsu K; Ono S; Hamaoka T; Fujiwara H; Kitagawa M; Azuma I; Yamamura Y
Gan; 1979 Feb; 70(1):101-7. PubMed ID: 109342
[TBL] [Abstract][Full Text] [Related]
60. Phase I study of intravenous mycobacterial cell wall skeleton and trehalose dimycolate attached to oil droplets.
Vosika G; Giddings C; Gray GR
J Biol Response Mod; 1984 Dec; 3(6):620-6. PubMed ID: 6512562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
